Geoffrey H Tison1, Alanna M Chamberlain2, Mark J Pletcher3, Shannon M Dunlay4, Susan A Weston2, Jill M Killian2, Jeffrey E Olgin5, Véronique L Roger6. 1. Division of Cardiology, University of California, San Francisco, USA. Electronic address: geoff.tison@ucsf.edu. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, USA. 4. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. 5. Division of Cardiology, University of California, San Francisco, USA. 6. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Heart failure (HF) is a major clinical and public health problem, the management of which will benefit from large-scale pragmatic research that leverages electronic medical records (EMR). Requisite to using EMRs for HF research is the development of reliable algorithms to identify HF patients. We aimed to develop and validate computable phenotype algorithms to identify patients with HF using standardized data elements defined by the Patient Centered Outcomes Research Network (PCORnet) Common Data Model (CDM). METHODS: We built HF computable phenotypes utilizing the data domains of HF diagnosis codes, prescribed HF-related medications and N-terminal B-type natriuretic peptide (NT-proBNP). Algorithms were validated in a cohort (n = 76,254) drawn from Olmsted County, MN between 2010-2012 a sample of whose records were manually reviewed to confirm HF according to Framingham criteria. RESULTS: The different algorithms we tested provided different tradeoffs between sensitivity and positive predictive value (PPV). The highest sensitivity (78.7%) algorithm utilized one HF diagnosis code and had the lowest PPV (68.5%). The addition of more algorithm components, such as additional HF diagnosis codes, HF medications or elevated NT-proBNP, improved the PPV while reducing sensitivity. When added to a diagnostic code, the addition of NT-proBNP (>450 pg/mL) had a similar impact compared to additional HF medication criteria, increasing PPV by ∼3-4% and decreasing sensitivity by ∼7-10%. CONCLUSIONS: Algorithms derived from PCORnet CDM elements can be used to identify patients with HF without manual adjudication with reasonable sensitivity and PPV. Algorithm choice should be driven by the goal of the research.
BACKGROUND:Heart failure (HF) is a major clinical and public health problem, the management of which will benefit from large-scale pragmatic research that leverages electronic medical records (EMR). Requisite to using EMRs for HF research is the development of reliable algorithms to identify HFpatients. We aimed to develop and validate computable phenotype algorithms to identify patients with HF using standardized data elements defined by the Patient Centered Outcomes Research Network (PCORnet) Common Data Model (CDM). METHODS: We built HF computable phenotypes utilizing the data domains of HF diagnosis codes, prescribed HF-related medications and N-terminal B-type natriuretic peptide (NT-proBNP). Algorithms were validated in a cohort (n = 76,254) drawn from Olmsted County, MN between 2010-2012 a sample of whose records were manually reviewed to confirm HF according to Framingham criteria. RESULTS: The different algorithms we tested provided different tradeoffs between sensitivity and positive predictive value (PPV). The highest sensitivity (78.7%) algorithm utilized one HF diagnosis code and had the lowest PPV (68.5%). The addition of more algorithm components, such as additional HF diagnosis codes, HF medications or elevated NT-proBNP, improved the PPV while reducing sensitivity. When added to a diagnostic code, the addition of NT-proBNP (>450 pg/mL) had a similar impact compared to additional HF medication criteria, increasing PPV by ∼3-4% and decreasing sensitivity by ∼7-10%. CONCLUSIONS: Algorithms derived from PCORnet CDM elements can be used to identify patients with HF without manual adjudication with reasonable sensitivity and PPV. Algorithm choice should be driven by the goal of the research.
Authors: Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: Qian Li; Robert J Glynn; Nancy A Dreyer; Jun Liu; Helen Mogun; Soko Setoguchi Journal: Pharmacoepidemiol Drug Saf Date: 2011-05-14 Impact factor: 2.890
Authors: Suzette J Bielinski; Jyotishman Pathak; David S Carrell; Paul Y Takahashi; Janet E Olson; Nicholas B Larson; Hongfang Liu; Sunghwan Sohn; Quinn S Wells; Joshua C Denny; Laura J Rasmussen-Torvik; Jennifer Allen Pacheco; Kathryn L Jackson; Timothy G Lesnick; Rachel E Gullerud; Paul A Decker; Naveen L Pereira; Euijung Ryu; Richard A Dart; Peggy Peissig; James G Linneman; Gail P Jarvik; Eric B Larson; Jonathan A Bock; Gerard C Tromp; Mariza de Andrade; Véronique L Roger Journal: J Cardiovasc Transl Res Date: 2015-07-21 Impact factor: 4.132
Authors: Saul Blecker; Stuart D Katz; Leora I Horwitz; Gilad Kuperman; Hannah Park; Alex Gold; David Sontag Journal: JAMA Cardiol Date: 2016-12-01 Impact factor: 14.676
Authors: Rachael L Fleurence; Lesley H Curtis; Robert M Califf; Richard Platt; Joe V Selby; Jeffrey S Brown Journal: J Am Med Inform Assoc Date: 2014-05-12 Impact factor: 4.497
Authors: L J Finney Rutten; A Alexander; P J Embi; G Flores; C Friedman; I V Haller; P Haug; D Jensen; S Khosla; G Runger; N D Shah; T Winden; V L Roger Journal: J Clin Transl Sci Date: 2017-02-02
Authors: Andrea L Oliverio; Dorota Marchel; Jonathan P Troost; Isabelle Ayoub; Salem Almaani; Jessica Greco; Cheryl L Tran; Michelle R Denburg; Michael Matheny; Chad Dorn; Susan F Massengill; Hailey Desmond; Debbie S Gipson; Laura H Mariani Journal: Kidney360 Date: 2021-09-27
Authors: Sheila M Manemann; David S Knopman; Jennifer St Sauver; Suzette J Bielinski; Alanna M Chamberlain; Susan A Weston; Ruoxiang Jiang; Véronique L Roger Journal: J Am Geriatr Soc Date: 2022-03-18 Impact factor: 7.538
Authors: Rohit Vijh; Sabrina T Wong; Matthew Grandy; Sandra Peterson; Allison M Ezzat; Andrew G Gibb; Nathaniel M Hawkins Journal: CMAJ Open Date: 2021-04-16
Authors: Amitava Banerjee; Laura Pasea; Sheng-Chia Chung; Kenan Direk; Folkert W. Asselbergs; Diederick E Grobbee; Dipak Kotecha; Stefan D Anker; Tomasz Dyszynski; Benoît Tyl; Spiros Denaxas; R Thomas Lumbers; Harry Hemingway Journal: Eur J Heart Fail Date: 2022-01-26 Impact factor: 17.349
Authors: Carlton R Moore; Saumya Jain; Stephanie Haas; Harish Yadav; Eric Whitsel; Wayne Rosamand; Gerardo Heiss; Anna M Kucharska-Newton Journal: BMJ Open Date: 2021-06-14 Impact factor: 2.692
Authors: Pascal S Brandt; Richard C Kiefer; Jennifer A Pacheco; Prakash Adekkanattu; Evan T Sholle; Faraz S Ahmad; Jie Xu; Zhenxing Xu; Jessica S Ancker; Fei Wang; Yuan Luo; Guoqian Jiang; Jyotishman Pathak; Luke V Rasmussen Journal: Learn Health Syst Date: 2020-06-25